Kangmei Pharma Invests $44 Million In 2 TCM Companies

July 29, 2010 -- Kangmei Pharmaceutical will purchase the pharmaceutical assets of two TCM companies from the Langzhong government in Sichuan province: Sichuan Tengwangge Pharmaceutical and Sichuan Baoning Pharmaceutical. The company will invest 300 million RMB ($44 million) in Langzhong’s healthcare sector in the next two years. More details....

Stock Symbol: (SHEX: 600518)

MORE ON THIS TOPIC